MiMedx Group Launches CHORIOFIX Placental Allograft for Complex Wounds
MiMedx Group (NASDAQ:MDXG) has launched its new placental allograft, CHORIOFIX, designed to treat complex and tunneling wounds. The product features a triple-layer construction and is part of the company's portfolio of advanced wound care solutions.
Topics: biotech placental_allograft product_launch wound_care